drugset / Trial / NCT01603615
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the long-term safety of BOTOX® (botulinum toxin Type A) for the treatment of pediatric upper limb spasticity.
Timeline
- Start
- 2012-10-30
- Primary completion
- 2018-09-03
- Completion
- 2018-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 6 iu/kg | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 8 iu/kg | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 10 iu/kg | Intramuscular |